Study clinical trials phase iii as topic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases35

Neoplasms Lung Neoplasms Breast Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Colorectal Neoplasms Recurrence Nausea Neoplasm Recurrence, Local Drug-Related Side Effects and Adverse Reactions Neutropenia Adenocarcinoma Prostatic Neoplasms HIV Infections Melanoma Stroke Vomiting Ovarian Neoplasms Pain Acute Disease Carcinoma, Small Cell Brain Neoplasms Chronic Disease Head and Neck Neoplasms Pancreatic Neoplasms Kidney Neoplasms Fatigue Carcinoma, Renal Cell Leukopenia Carcinoma, Squamous Cell Hematologic Diseases Multiple Myeloma Hot Flashes Skin Neoplasms

Chemicals and Drugs68

Placebos Antineoplastic Agents Cisplatin Fluorouracil Deoxycytidine Paclitaxel Taxoids Antibodies, Monoclonal, Humanized Vinblastine Drugs, Investigational Carboplatin Doxorubicin Cyclophosphamide Leucovorin Antibodies, Monoclonal Antimetabolites, Antineoplastic Organoplatinum Compounds Epirubicin Vincristine Methotrexate Antineoplastic Agents, Phytogenic Etoposide Camptothecin Drug Combinations Quinazolines Prednisone Cancer Vaccines Megestrol Acetate Angiogenesis Inhibitors Thiophenes Recombinant Proteins Antineoplastic Agents, Hormonal Antithrombin III Mitomycin RNA Polymerase III Dacarbazine Biological Markers Tumor Markers, Biological Pyrroles Interferon-alpha Ifosfamide Protein Kinase Inhibitors Motilin Triazoles Niacinamide Androstenols Antineoplastic Agents, Alkylating Anti-Bacterial Agents Tamoxifen Vindesine Phenylurea Compounds Anticoagulants Immunologic Factors Platinum Compounds Indoles Benzenesulfonates Pyrimidines Anthracyclines Topotecan Antibiotics, Antineoplastic Polyethylene Glycols Immunosuppressive Agents Vaginal Creams, Foams, and Jellies Nitriles Piperazines Pyridines Guanine Pyridones

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Clinical Trials, Phase III as Topic Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase II as Topic Double-Blind Method Research Design Randomized Controlled Trials as Topic Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase I as Topic Drug Administration Schedule Placebos Controlled Clinical Trials as Topic Multicenter Studies as Topic Disease-Free Survival Clinical Trials, Phase IV as Topic Patient Selection Survival Analysis Prospective Studies Combined Modality Therapy Follow-Up Studies Early Termination of Clinical Trials Survival Rate Endpoint Determination Clinical Protocols Chemotherapy, Adjuvant Single-Blind Method Neoplasm Staging Infusions, Intravenous Administration, Oral Drug Therapy, Combination Sample Size Kaplan-Meier Estimate Prognosis Pilot Projects Severity of Illness Index Questionnaires Risk Factors Risk Assessment Treatment Failure Drug Approval Meta-Analysis as Topic Reproducibility of Results Proportional Hazards Models Feasibility Studies Radiotherapy, Adjuvant Remission Induction Drug Evaluation Retrospective Studies Data Interpretation, Statistical Immunotherapy Random Allocation Cross-Over Studies Molecular Targeted Therapy Pain Measurement Neoadjuvant Therapy Statistics, Nonparametric Multivariate Analysis Analysis of Variance Predictive Value of Tests Drug Evaluation, Preclinical Dose Fractionation Maximum Tolerated Dose Interviews as Topic Models, Statistical Injections, Subcutaneous Phytotherapy Palliative Care Exercise Therapy Statistics as Topic Maintenance Chemotherapy Radiotherapy Dosage Injections, Intravenous Therapeutic Human Experimentation Data Collection Sensitivity and Specificity Probability Chi-Square Distribution Therapies, Investigational Incidence Cohort Studies Individualized Medicine Radiotherapy Vaginal Creams, Foams, and Jellies Drug Design Models, Biological Chemoradiotherapy Odds Ratio Drug Delivery Systems Logistic Models

Psychiatry and Psychology4

Patient Compliance Pain Cognitive Therapy Decision Making

Phenomena and Processes12

Time Factors Dose-Response Relationship, Drug Myoelectric Complex, Migrating Pain Maximum Tolerated Dose Drug Resistance, Neoplasm Sensitivity and Specificity Probability Chi-Square Distribution Pregnancy Algorithms Odds Ratio

Disciplines and Occupations11

Research Design Evidence-Based Medicine Medical Oncology Biomedical Research Outcome Assessment (Health Care)Statistics as Topic Translational Medical Research Therapeutic Human Experimentation Individualized Medicine Drug Design Research

Anthropology, Education, Sociology and Social Phenomena10

Quality of Life Drug Approval Patient Education as Topic National Cancer Institute (U.S.)United States Food and Drug Administration Informed Consent National Institutes of Health (U.S.)International Cooperation Survival Programmed Instruction as Topic

Technology, Industry, Agriculture3

Drug Industry Dietary Supplements Polyethylene Glycols

Humanities3

Quality of Life Therapeutic Equipoise Conflict of Interest

Information Science14

Survival Rate Periodicals as Topic Questionnaires Review Literature as Topic Abstracting and Indexing as Topic Data Interpretation, Statistical Textbooks as Topic Terminology as Topic Publishing Interviews as Topic Internet Data Collection Incidence Algorithms

Named Groups3

Research Subjects Infant, Newborn Patient Dropouts

Health Care75

Clinical Trials, Phase III as Topic Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase II as Topic Double-Blind Method Randomized Controlled Trials as Topic Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Multicenter Studies as Topic Disease-Free Survival Clinical Trials, Phase IV as Topic Patient Selection Survival Analysis Prospective Studies Follow-Up Studies Early Termination of Clinical Trials Survival Rate Clinical Protocols Single-Blind Method Clinical Trials Data Monitoring Committees Sample Size Kaplan-Meier Estimate Congresses as Topic Pilot Projects Severity of Illness Index Cost-Benefit Analysis Guidelines as Topic Questionnaires Risk Factors Risk Assessment Outcome Assessment (Health Care)Treatment Failure Meta-Analysis as Topic Practice Guidelines as Topic Reproducibility of Results Proportional Hazards Models Feasibility Studies Patient Compliance Patient Education as Topic National Cancer Institute (U.S.)Retrospective Studies Data Interpretation, Statistical United States Food and Drug Administration Random Allocation Safety Cross-Over Studies Informed Consent Research Support as Topic Statistics, Nonparametric Multivariate Analysis Analysis of Variance Predictive Value of Tests Placebo Effect Patient Participation Societies, Medical National Institutes of Health (U.S.)Patient Satisfaction Age Factors Interviews as Topic Benchmarking Models, Statistical Bias (Epidemiology)International Agencies Palliative Care Statistics as Topic Data Collection Intention to Treat Analysis Sensitivity and Specificity Probability Conflict of Interest Chi-Square Distribution Incidence Cohort Studies Odds Ratio Logistic Models

Publication Characteristics1

Clinical Trial, Phase III

Geographicals6

United States Europe Great Britain Canada Germany Japan

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Publication Characteristics Geographicals

Clinical Trials, Phase III as Topic Clinical Trials as Topic Treatment Outcome Clinical Trials, Phase II as Topic Double-Blind Method Research Design Randomized Controlled Trials as Topic Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase I as Topic Drug Administration Schedule Placebos Antineoplastic Agents Controlled Clinical Trials as Topic Multicenter Studies as Topic Disease-Free Survival Clinical Trials, Phase IV as Topic Patient Selection Time Factors Survival Analysis Cisplatin Prospective Studies Neoplasms Fluorouracil Combined Modality Therapy Follow-Up Studies Quality of Life Deoxycytidine Lung Neoplasms Early Termination of Clinical Trials Survival Rate Endpoint Determination Clinical Protocols Paclitaxel Chemotherapy, Adjuvant Single-Blind Method Taxoids Neoplasm Staging Evidence-Based Medicine Infusions, Intravenous Breast Neoplasms Antibodies, Monoclonal, Humanized Administration, Oral Drug Therapy, Combination Clinical Trials Data Monitoring Committees United States Dose-Response Relationship, Drug Sample Size Disease Progression Carcinoma, Non-Small-Cell Lung Vinblastine Drugs, Investigational Kaplan-Meier Estimate Prognosis Periodicals as Topic Carboplatin Congresses as Topic Doxorubicin Medical Oncology Pilot Projects Neoplasm Metastasis Cyclophosphamide Severity of Illness Index Leucovorin Antibodies, Monoclonal Cost-Benefit Analysis Antimetabolites, Antineoplastic Guidelines as Topic Questionnaires Myoelectric Complex, Migrating Risk Factors Biomedical Research Risk Assessment Outcome Assessment (Health Care)Treatment Failure Colorectal Neoplasms Drug Approval Meta-Analysis as Topic Recurrence Organoplatinum Compounds Review Literature as Topic Practice Guidelines as Topic Nausea Research Subjects Reproducibility of Results Epirubicin Proportional Hazards Models Feasibility Studies Neoplasm Recurrence, Local Europe Patient Compliance Drug-Related Side Effects and Adverse Reactions Vincristine Methotrexate Patient Education as Topic Clinical Trial, Phase III Antineoplastic Agents, Phytogenic Abstracting and Indexing as Topic Radiotherapy, Adjuvant National Cancer Institute (U.S.)Remission Induction

No FAQ available that match "study clinical trials phase iii as topic"